Variables | Participants | P value | Effect size (d) | |
---|---|---|---|---|
Post-ACLR athletes (n = 21) mean ± SD (range) | Healthy subjects (n = 17) mean ± SD (range) | |||
SHD (%) | 95.0 ± 6.7 (85.3–117.8) | 95.4 ± 2.6 (91.1–99.7) | 0.900 | 0.08 |
THD (%) | 94.9 ± 5.5 (83.7–108.3) | 95.7 ± 3.4 (87.9–99.3) | 0.631 | 0.17 |
CHD (%) | 93.9 ± 5.8 (82.1–103.7) | 95.9 ± 2.6 (91.3–99.9) | 0.184 | 0.43 |
CT during SVCJs (%) | 94.3 ± 4.9 (86.6–103.9) | 97.0 ± 2.4 (90.0–99.9) | 0.034 | 0.68 |
JH during SVCJs (%) | 86.0 ± 12.8 (66.9–120.8) | 91.6 ± 5.6 (79.6–100.0) | 0.106 | 0.55 |
RSI during SVCJs (%) | 81.4 ± 14.8 (58.1–125.5) | 90.6 ± 5.9 (78.8–98.9) | 0.015 | 0.79 |